AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$752M |
| 2 |
Home Depot
HD
|
+$643M |
| 3 |
Netflix
NFLX
|
+$566M |
| 4 |
West Pharmaceutical
WST
|
+$566M |
| 5 |
Celsius Holdings
CELH
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.22B |
| 2 |
Nike
NKE
|
+$872M |
| 3 |
MSCI
MSCI
|
+$831M |
| 4 |
Fortinet
FTNT
|
+$789M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$532M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.82% |
| 2 | Healthcare | 15.99% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
W.W. Grainger
GWW
$65.3B
| $65.8M | 0.02% |
72,956
-296
| -0.4% | -$278K |
|
527
Viking Therapeutics
VKTX
$4.04B
| $65.8M | 0.02% |
1,241,125
-319,753
| -20% | -$21M |
|
528
Autodesk
ADSK
$44.3B
| $65.7M | 0.02% |
265,470
-1,366,283
| -84% | -$307M |
|
529
Quest Diagnostics
DGX
$25.1B
| $65.6M | 0.02% |
479,598
+20,724
| +5% | +$2.84M |
|
530
BrightSpring Health Services
BTSG
$14.3B
| $65.6M | 0.02% |
5,778,781
+194,891
| +3% | +$2.13M |
|
531
Aon
AON
$77.3B
| $65.5M | 0.02% |
223,003
+3,835
| +2% | +$1.13M |
|
|
PDS
532
Precision Drilling
PDS
$1.09B
| $65.4M | 0.02% |
+1,100
| New | +$77.4K |
|
533
Biogen
BIIB
$29.9B
| $65.2M | 0.02% |
281,289
+79,398
| +39% | +$17.3M |
|
534
TPG
TPG
$6.87B
| $65.2M | 0.02% |
1,572,430
-105,844
| -6% | -$4.53M |
|
535
Ascendis Pharma A/S
ASND
$16.7B
| $64.8M | 0.02% |
475,001
+1,248
| +0.3% | +$170K |
|
536
Core & Main
CNM
$8.17B
| $64.7M | 0.02% |
1,322,994
-297,772
| -18% | -$16.5M |
|
537
Ameriprise Financial
AMP
$46.8B
| $64.7M | 0.02% |
151,369
-952
| -0.6% | -$407K |
|
538
Arthur J. Gallagher & Co
AJG
$63.7B
| $64.3M | 0.02% |
247,882
-1,963
| -0.8% | -$487K |
|
539
Rubrik
RBRK
$15.1B
| $64.3M | 0.02% |
+2,096,112
| New | +$68.9M |
|
540
Ultragenyx Pharmaceutical
RARE
$2.65B
| $62.8M | 0.02% |
1,527,875
+45,404
| +3% | +$1.94M |
|
|
BNY
541
Bank of New York Mellon
BNY
$108B
| $62.7M | 0.02% |
1,047,124
-42,621
| -4% | -$2.47M |
|
542
BridgeBio Pharma
BBIO
$16.5B
| $62.1M | 0.02% |
2,452,404
-391,895
| -14% | -$10.7M |
|
543
UDR
UDR
$12.9B
| $62.1M | 0.02% |
1,508,905
+964,784
| +177% | +$37.2M |
|
544
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
| $62M | 0.02% |
861,360
-113,464
| -12% | -$7.96M |
|
545
PJT Partners
PJT
$4.37B
| $62M | 0.02% |
574,441
-59,570
| -9% | -$5.98M |
|
546
Hilton Worldwide
HLT
$74B
| $61.8M | 0.02% |
283,095
-9,698
| -3% | -$1.99M |
|
547
Williams Companies
WMB
$90.5B
| $61.7M | 0.02% |
1,451,177
-44,721
| -3% | -$1.79M |
|
548
Marriott International
MAR
$98.7B
| $61.6M | 0.02% |
254,624
-9,829
| -4% | -$2.36M |
|
|
CERE
549
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $61.1M | 0.02% |
1,494,341
+321,454
| +27% | +$13.4M |
|
|
SUM
550
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $60.6M | 0.02% |
1,655,960
-426,756
| -20% | -$16.7M |
|
Similar funds
AllianceBernstein's Q2 2024 Portfolio in Review
As of Q2 2024, AllianceBernstein held 3,360 positions worth $287B, up 1.5% from $283B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
AllianceBernstein's Q2 2024 filing shows 222 new, 1,541 increased, 1,167 reduced and 129 closed positions. Its largest new stake was On Holding: 11,175,290 shares worth $434M. The largest sale was UnitedHealth, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q2 2024 buy was On Holding: 11,175,290 shares worth $434M.
- AllianceBernstein added most to Texas Instruments in Q2 2024, an estimated $752M increase.
- AllianceBernstein's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.22B.
- AllianceBernstein fully exited Apartment Income REIT Corp. in Q2 2024, selling an estimated $157M.
- AllianceBernstein's ten largest holdings make up 29% of its $287B portfolio in Q2 2024.
- AllianceBernstein opened 222 new positions and closed 129 in Q2 2024.
- AllianceBernstein's portfolio value rose 1.5% quarter-over-quarter to $287B.
Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.